Article
Association Between Tumor Mutation Burden (TMB) and immune microenvironment in lung squamous cell carcinoma
2020-11-19
Abstract excerpt
<title>Abstract</title> <p><bold>Background </bold>Tumor mutational burden (TMB) is an emerging biomarker for selecting patients with non-small cell lung cancer (NSCLC) for immunotherapy. And many studies have revealed high-TMB may be significantly associated with response to PD-1 and PD-L1 blockade immunotherapy.<bold>Methods </bold>The RNA-seq transcriptome profiling, simple nucleotide variation and correspondi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 65945359-95fa-5b3b-be98-78fbb08a0c49
- DOI
- 10.21203/rs.3.rs-110577/v1
